Walgreens Shareholders Approve $10 Billion Private Equity Buyout

Published: Friday, July 11, 2025 at 2:10 pm

Walgreens Shareholders Greenlight $10 Billion Private Equity Buyout

Walgreens Boots Alliance shareholders have approved a $10 billion buyout offer from private equity firm Sycamore Partners. The deal, announced in March, will see Sycamore Partners pay $11.45 per share, a 29% premium over Walgreens' December stock price. Sycamore also agreed to a potential additional cash payment of up to $3 per share from the future monetization of Walgreens' interests in VillageMD, encompassing Village Medical, Summit Health, and CityMD.

The shareholder vote, held at a special meeting, saw approximately 96% of votes cast in favor of the merger agreement. Walgreens CEO Tim Wentworth expressed appreciation for the shareholders' support, stating that the partnership with Sycamore will accelerate the company's turnaround strategy and enhance the customer, patient, and team member experience.

Walgreens anticipates closing the transaction in the third or fourth quarter of this year, pending regulatory approvals. The buyout follows a period of financial challenges for the drugstore chain. Walgreens, once valued at over $100 billion, faced difficulties after a failed in-store clinic rollout, leading to store closures to reduce debt and mitigate losses.

Under former CEO Roz Brewer, Walgreens invested billions in physician-staffed clinic operator VillageMD, aiming to establish hundreds of clinics. However, the expansion plans were scaled back due to challenges in filling patient panels. The VillageMD investment contributed significantly to the company's fiscal 2024 net loss of over $8 billion.

BNN's Perspective:

This deal highlights the evolving landscape of the healthcare and retail industries. While the buyout offers a potential fresh start for Walgreens, the challenges faced by the company underscore the risks associated with ambitious expansion strategies and the importance of adapting to changing market dynamics. The success of this partnership will depend on Sycamore Partners' ability to navigate the complexities of the healthcare sector and revitalize Walgreens' core business.

Keywords: Walgreens, Sycamore Partners, buyout, shareholders, VillageMD, merger, healthcare, retail, Tim Wentworth, Roz Brewer, clinic, financial losses, stock price, private equity

Full Story